Regional homovanillic acid production in humans.
暂无分享,去创建一个
G. Jennings | M. Esler | G. Eisenhofer | G. Lambert | G Eisenhofer | M D Esler | G L Jennings | G W Lambert | G. Lambert | Graeme Eisenhofer | G. L. Jennings
[1] B. Brooks,et al. Relationship between norepinephrine in blood and cerebrospinal fluid in the presence of a blood cerebrospinal fluid barrier for norepinephrine , 1977, Journal of neurochemistry.
[2] W. Anderson,et al. Assessment of human sympathetic nervous system activity from measurements of norepinephrine turnover. , 1988, Hypertension.
[3] R. Shipley,et al. Tracer methods for in-vivo kinetics;: Theory and applications , 1972 .
[4] J. Axelrod,et al. Blood-Brain Barrier for Adrenaline , 1959, Science.
[5] D. Goldstein,et al. Plasma dihydroxyphenylglycol for estimation of noradrenaline neuronal re-uptake in the sympathetic nervous system in vivo. , 1989, Clinical science.
[6] I. Kopin,et al. Kinetics of homovanillic acid and determination of its production rate in the rhesus monkey. , 1979, Life sciences.
[7] C. Bowden,et al. Effects of debrisoquin on CSF and plasma HVA concentrations in man. , 1985, Life sciences.
[8] J. Hsiao,et al. Effects of renal clearance on plasma concentrations of homovanillic acid. Methodologic cautions. , 1989, Archives of general psychiatry.
[9] J. Kelsoe,et al. Plasma Homovanillic Acid as an Index of Central Dopaminergic Activity: Studies in Schizophrenic Patients , 1988, Annals of the New York Academy of Sciences.
[10] C. Bowden,et al. Dopamine metabolism and disposition in schizophrenic patients. Studies using debrisoquin. , 1988, Archives of general psychiatry.
[11] J. Maas,et al. A DIRECT METHOD FOR DETERMINING DOPAMINE SYNTHESIS AND OUTPUT OF DOPAMINE METABOLITES FROM BRAIN IN AWAKE ANIMALS , 1979, Journal of neurochemistry.
[12] J. M. Doidge,et al. Adrenergic and non-adrenergic inhibitory nerves in mammalian airways. , 1982, Journal of the autonomic nervous system.
[13] D. Goldstein,et al. Neuronal source of plasma dihydroxyphenylalanine. , 1987, The Journal of clinical endocrinology and metabolism.
[14] C. Altar,et al. Dopamine release in vivo from nigrostriatal, mesolimbic, and mesocortical neurons: utility of 3-methoxytyramine measurements. , 1988, Pharmacological reviews.
[15] I. Meredith,et al. Overflow of catecholamine neurotransmitters to the circulation: source, fate, and functions. , 1990, Physiological reviews.
[16] K. Davis,et al. Control of exogenous factors affecting plasma homovanillic acid concentration , 1987, Psychiatry Research.
[17] I. Kopin,et al. Catecholamine metabolism: basic aspects and clinical significance. , 1985, Pharmacological reviews.
[18] A. Quyyumi,et al. Sympathetic Nervous Function in Human Heart as Assessed by Cardiac Spillovers of Dihydroxyphenylglycol and Norepinephrine , 1992, Circulation.
[19] I. Kopin,et al. Relationship between urinary excretion of homovanillic acid and norepinephrine metabolites in normal subjects and patients with orthostatic hypotension. , 1988, Life sciences.
[20] P. Korner,et al. Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous activity. , 1986, Circulation.
[21] I. Kopin,et al. Kinetics of Homovanillie Acid and Determination of Its Production Rate in Humans , 1982, Journal of neurochemistry.
[22] I. Kopin,et al. Contribution of plasma homovanillic acid (HVA) to urine and cerebrospinal fluid HVA in the monkey and its pharmacokinetic disposition. , 1978, Life sciences.
[23] R. Roth,et al. 3,4-Dihydroxyphenylacetic acid and homovanillic acid in rat plasma: possible indicators of central dopaminergic activity. , 1979, European journal of pharmacology.
[24] J. Kleinman,et al. Dopamine and its metabolites in human peripheral nerves: is there a widely distributed system of peripheral dopaminergic nerves? , 1981, Life sciences.
[25] O. Hornykiewicz. Dopamine in the basal ganglia. Its role and therapeutic implications (including the clinical use of L-DOPA). , 1973, British medical bulletin.
[26] R. Wurtman,et al. EFFECT OF SELECTIVE DESTRUCTION OF CENTRAL AND PERIPHERAL CATECHOLAMINE‐CONTAINING NEURONES WITH 6‐HYDROXYDOPAMINE ON CATECHOLAMINE EXCRETION IN THE RAT , 1974, British journal of pharmacology.
[27] B. G. Wolthers,et al. Injurious effect of EDTA contamination on colorimetry of serum iron. , 1985, Clinical chemistry.
[28] I. Meredith,et al. Increased plasma dihydroxyphenylalanine during sympathetic activation in humans is related to increased norepinephrine turnover. , 1991, The Journal of laboratory and clinical medicine.
[29] G. Jennings,et al. Direct determination of homovanillic acid release from the human brain, an indicator of central dopaminergic activity. , 1991, Life sciences.
[30] A. Quyyumi,et al. Regional extraction of circulating norepinephrine, DOPA, and dihydroxyphenylglycol in humans. , 1991, Journal of the autonomic nervous system.
[31] S. Stahl,et al. The dopamine hypothesis of schizophrenia: a review. , 1976, Schizophrenia bulletin.